← Ascendis Pharma A/S
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Net Income | — | — | — | — | — | — | ($583.2m) |
($481.4m)
+17.45%
|
($378.1m)
+21.47%
|
($228.0m)
+39.69%
|
$495.9m
+317.48%
|
|
| Profit or Loss | ($68.5m) | ($123.9m) | ($130.1m) | ($218.0m) | ($419.0m) | ($383.6m) | ($583.2m) | ($481.4m) | ($378.1m) | ($228.0m) | — | |
| Depreciation | $677k | $734k | $880k | $6.7m | $9.4m | $14.9m | $17.5m | $18.4m | $17.2m | $17.2m | $17.2m | |
| Amortization | — | — | — | — | — | $445k | $444k | $483k | $467k | $490k | $490k | |
| Depreciation Amortization Depletion | — | — | — | — | — | — | $18.0m | $18.9m | $17.7m | $17.7m | $17.4m | |
| Adjustments For Deferred Tax Of Prior Periods | — | — | — | — | — | — | — | ($4.8m) | $607k | $70k | — | |
| Deferred Tax | — | — | — | — | — | — | $5.4m | $7.3m | $4.8m | $15.4m | ($663.2m) | |
| Adjustments For Share-Based Payments | $7.3m | $9.7m | $19.7m | $37.5m | $53.2m | $66.8m | $64.2m | $66.7m | $95.5m | $116.2m | — | |
| Asset Impairment Charge | — | — | — | — | — | — | $0 | $7.8m | $0 | $5.3m | ($2.2m) | |
| Earnings (Loss)es From Equity Investments | — | — | — | — | — | — | $17.7m | $18.4m | $20.1m | ($16.3m) | $20.5m | |
| Change In Working Capital | — | — | — | — | — | — | ($12.5m) | ($99.8m) | ($107.2m) | $71.0m | ($46.4m) | |
| Receivables | — | ($671k) | ($183k) | ($1.9m) | ($2.0m) | ($6.7m) | ($11.5m) | ($32.8m) | ($118.6m) | $15.6m | ($118.8m) | |
| Inventories | — | — | — | — | — | ($75.4m) | ($55.3m) | ($78.3m) | ($86.7m) | ($5.9m) | ($21.3m) | |
| Change In Inventory | — | — | — | — | — | — | ($55.3m) | ($78.3m) | ($86.7m) | ($5.9m) | ($21.3m) | |
| Trade payables, accrued expenses and other liabilities | $4.7m | $10.8m | $8.3m | $7.5m | $7.9m | $39.2m | $45.9m | $3.6m | $27.0m | ($10.4m) | — | |
| Change In Payables And Accrued Expense | — | — | — | — | — | — | $45.9m | $3.6m | $27.0m | ($10.4m) | $9.3m | |
| Proceeds From Sales Of Property Plant And Equipment Classified As Investing Activities | ($672k) | ($941k) | ($2.6m) | ($5.2m) | $5.1m | $0 | $0 | $51k | $950k | $0 | — | |
| Capital Expenditure | — | — | — | — | — | — | ($14.5m) | ($2.4m) | ($1.4m) | ($8.5m) | ($8.5m) | |
| Investments in associates | — | — | — | — | — | ($10.2m) | $0 | $0 | — | — | — | |
| Settlement of marketable securities | — | — | — | — | $263.1m | $149.9m | $280.5m | $288.9m | $7.4m | $0 | — | |
| Acquisitions of treasury shares, net of transactions costs | — | — | — | — | — | ($21.6m) | ($105.3m) | $0 | $0 | ($17.4m) | — | |
| Proceeds From Borrowings Classified As Financing Activities | — | — | — | — | — | — | — | $136.3m | $134.2m | $0 | — | |
| Repayments Of Borrowings Classified As Financing Activities | — | — | — | — | — | — | — | — | $11.4m | $22.0m | — | |
| Repayment of borrowings | — | — | — | — | — | — | ($6.4m) | ($10.4m) | ($11.4m) | ($22.0m) | — | |
| Net proceeds from borrowings | — | — | — | — | — | $0 | $503.3m | $136.3m | $134.2m | $0 | — | |
| Issuance Of Debt | — | — | — | — | — | — | $503.3m | $136.3m | $134.2m | $0 | $0 | |
| Long Term Debt Issuance | — | — | — | — | — | — | $503.3m | $136.3m | $134.2m | $0 | $0 | |
| Long Term Debt Payments | — | — | — | — | — | — | ($6.4m) | ($10.4m) | ($11.4m) | ($22.0m) | ($27.5m) | |
| Net Issuance Payments Of Debt | — | — | — | — | — | — | $496.9m | $125.8m | $122.8m | ($22.0m) | ($27.5m) | |
| Net Long Term Debt Issuance | — | — | — | — | — | — | $496.9m | $125.8m | $122.8m | ($22.0m) | ($27.5m) | |
| Repayment Of Debt | — | — | — | — | — | — | ($6.4m) | ($10.4m) | ($11.4m) | ($22.0m) | ($27.5m) | |
| Common Stock Issuance | — | — | — | — | — | — | $0 | $0 | $309.9m | $0 | $0 | |
| Common Stock Payments | — | — | — | — | — | — | ($105.3m) | $0 | $0 | ($17.4m) | ($51.9m) | |
| Issuance Of Capital Stock | — | — | — | — | — | — | $0 | $0 | $309.9m | $0 | $0 | |
| Net Common Stock Issuance | — | — | — | — | — | — | ($105.3m) | $0 | $309.9m | ($17.4m) | ($51.9m) | |
| Repurchase Of Capital Stock | — | — | — | — | — | — | ($105.3m) | $0 | $0 | ($17.4m) | ($51.9m) | |
| Net Other Financing Charges | — | — | — | — | — | ($21.6m) | — | ($1.8m) | ($19.3m) | ($11.4m) | ($8.0m) | |
| Increase/(decrease) in cash and cash equivalents | $56.6m | $28.7m | $61.8m | $312.5m | $39.9m | ($176.8m) | ($37.2m) | ($46.6m) | $144.6m | $81.7m | — | |
| Beginning Cash Position | — | — | — | — | — | — | $446.3m | $444.8m | $392.2m | $559.5m | $517.9m | |
| Effect of exchange rate changes on balances held in foreign currencies | $4.1m | ($13.7m) | $20.7m | $7.7m | ($53.5m) | $38.6m | $35.7m | ($6.0m) | $22.8m | ($25.2m) | ($8.6m) | |
| Additional Supplementary Disclosures | ||||||||||||
| Additional Supplementary Disclosures | ||||||||||||
| Additional Financial Items | ||||||||||||
| Adjustments For Current Tax Of Prior Period | — | — | — | — | — | — | — | $3.9m | ($126k) | $513k | — | |
| Adjustments For Decrease Increase In Trade Account Receivable | $777k | $99k | $182k | — | — | — | — | — | — | — | — | |
| Goodwill | $3.5m | $3.5m | $3.5m | $3.5m | — | — | — | — | — | — | ($2.2m) | |
| Income Taxes Paid Refund Classified As Operating Activities | ($558k) | ($153k) | ($332k) | $279k | ($1.1m) | ($152k) | $3k | $4.5m | $5.5m | $6.7m | — | |
| Interest Paid Classified As Financing Activities | — | — | — | — | — | $1.3m | ($9.3m) | ($15.7m) | ($15.2m) | ($22.9m) | — | |
| Payments Of Lease Liabilities Classified As Financing Activities | — | — | — | $4.0m | $4.8m | $6.4m | $6.4m | $10.4m | — | — | — | |
| Payments To Acquire Or Redeem Entitys Shares | — | — | — | — | — | $21.6m | $105.3m | $0 | $0 | $17.4m | — | |
| Proceeds From Disposal Or Maturity Of Availableforsale Financial Assets | — | — | — | — | $263.1m | $149.9m | $280.5m | $288.9m | — | — | — | |
| Proceeds From Issuing Shares | $126.0m | $133.1m | $216.4m | $529.3m | $638.8m | $367.9m | — | $0 | $309.9m | $0 | — | |
| Purchase Of Interests In Associates | — | — | — | — | — | $10.2m | — | $0 | — | — | — | |
| Net profit/(loss) for the year | ($68.5m) | ($123.9m) | ($130.1m) | ($218.0m) | ($419.0m) | ($383.6m) | ($583.2m) | ($481.4m) | ($378.1m) | ($228.0m) | — | |
| Reversal of finance income | ($7.3m) | ($923k) | ($24.7m) | ($17.8m) | ($1.8m) | ($59.7m) | ($52.2m) | ($43.9m) | ($25.6m) | ($114.0m) | — | |
| Reversal of finance expenses | $3.1m | $13.8m | $127k | $1.2m | $80.8m | $3.9m | $50.5m | $44.1m | $100.0m | $206.7m | — | |
| Reversal of income taxes | ($227k) | ($477k) | ($394k) | ($234k) | ($219k) | ($367k) | $5.4m | $7.3m | $4.8m | $15.4m | — | |
| Non-cash consideration relating to revenue | — | — | ($10.5m) | ($6.5m) | ($3.5m) | ($2.4m) | ($2.5m) | ($2.4m) | ($27.1m) | ($5.6m) | — | |
| Share of (profit)/loss of associates | — | — | $321k | $8.1m | $9.5m | ($12.0m) | $17.7m | $18.4m | $20.1m | ($16.3m) | — | |
| Prepayments | $1.9m | ($4.9m) | ($5.5m) | $4.8m | ($6.4m) | ($11.2m) | ($6.4m) | ($11.4m) | $10.4m | ($6.1m) | — | |
| Contract liabilities | ($3.0m) | ($94k) | $0 | ($6.0m) | ($495k) | $5.2m | $8.6m | ($7.1m) | ($1.2m) | $131k | — | |
| Provisions | — | — | — | — | — | $1.2m | $6.1m | $26.2m | $62.0m | $77.6m | — | |
| Cash flows generated from/(used in) operations | ($60.9m) | ($96.1m) | ($143.0m) | ($185.0m) | ($272.5m) | ($419.7m) | ($494.7m) | ($464.3m) | ($299.9m) | $68.2m | — | |
| Finance income received | $123k | $923k | $4.0m | $10.1m | $1.3m | $3.7m | $8.3m | $17.0m | $14.4m | $15.3m | — | |
| Finance expenses paid | ($5k) | ($97k) | ($127k) | ($717k) | ($1.5m) | ($1.8m) | ($9.3m) | ($15.7m) | ($15.2m) | ($22.9m) | — | |
| Cash flows from/(used in) investing activities | ($672k) | ($941k) | ($2.6m) | ($5.2m) | ($291.2m) | ($110.6m) | $61.7m | $286.5m | $6.9m | ($8.5m) | — | |
| Payment of principal portion of lease liabilities | — | — | — | ($4.0m) | ($4.8m) | ($6.4m) | ($6.4m) | ($10.4m) | — | — | — | |
| Proceeds from exercise of warrants | — | — | — | $17.4m | $26.9m | $11.5m | $5.2m | $10.3m | $30.5m | $87.1m | — | |
| Proceeds from follow-on public offering | $126.0m | $133.1m | $216.4m | $529.3m | $638.8m | $367.9m | $0 | $0 | $309.9m | $0 | — | |
| Costs of follow-on public offering | — | — | — | — | — | — | $0 | $0 | $19.3m | $0 | — | |
| Payment of withholding taxes under stock incentive programs | — | — | — | — | — | $0 | $0 | ($1.8m) | $0 | ($11.4m) | — | |
| Cash flows from/(used in) financing activities | $117.5m | $124.7m | $203.3m | $493.6m | $602.6m | $351.4m | $396.8m | $134.3m | $443.9m | $36.3m | — | |
| Cash and cash equivalents at January 1 | $180.3m | $195.4m | $277.9m | $598.1m | $584.5m | $446.3m | $444.8m | $392.2m | $559.5m | $616.0m | — | |
| Cash Flow From Continuing Financing Activities | — | — | — | — | — | — | $396.8m | $134.3m | $443.9m | $36.3m | $17.5m | |
| Cash Flow From Continuing Investing Activities | — | — | — | — | — | — | $61.7m | $286.5m | $6.9m | ($8.5m) | ($14.5m) | |
| Change In Cash Supplemental As Reported | — | — | — | — | — | — | ($37.2m) | ($46.6m) | $144.6m | $81.7m | — | |
| Change In Other Working Capital | — | — | — | — | — | — | $14.8m | $19.1m | $60.8m | $77.7m | $89.8m | |
| Change In Prepaid Assets | — | — | — | — | — | — | ($6.4m) | ($11.4m) | $10.4m | ($6.1m) | ($5.4m) | |
| Changes In Cash | — | — | — | — | — | — | ($37.2m) | ($46.6m) | $144.6m | $81.7m | $63.5m | |
| End Cash Position | — | — | — | — | — | — | $444.8m | $392.2m | $559.5m | $616.0m | $581.4m | |
| Financing Cash Flow | — | — | — | — | — | — | $396.8m |
$134.3m
-66.15%
|
$443.9m
+230.57%
|
$36.3m
-91.82%
|
$17.5m
-51.78%
|
|
| Free Cash Flow | — | — | — | — | — | — | ($510.2m) | ($469.8m) | ($307.6m) | $45.4m | $52.0m | |
| Gain Loss On Sale Of PPE | — | — | — | — | — | — | $22k | $5k | ($91k) | $0 | $0 | |
| Interest Received CFO | — | — | — | — | — | — | $8.3m | $17.0m | $14.4m | $15.3m | $15.6m | |
| Investing Cash Flow | — | — | — | — | — | — | $61.7m | $286.5m | $6.9m | ($8.5m) | ($14.5m) | |
| Net Business Purchase And Sale | — | — | — | — | — | ($10.2m) | $0 | $0 | — | — | — | |
| Net Intangibles Purchase And Sale | — | — | — | — | — | ($530k) | $0 | $0 | — | — | — | |
| Net Investment Purchase And Sale | — | — | — | — | — | — | $66.7m | $288.9m | $7.4m | $0 | $0 | |
| Net PPE Purchase And Sale | — | — | — | — | — | — | ($5.0m) | ($2.4m) | ($477k) | ($8.5m) | ($7.5m) | |
| Operating Gains Losses | — | — | — | — | — | — | $17.7m | $18.4m | $20.0m | ($16.3m) | $20.5m | |
| Other Non Cash Items | — | — | — | — | — | — | ($4.2m) | ($2.1m) | $47.3m | $87.1m | — | |
| Proceeds From Stock Option Exercised | — | — | — | — | — | — | $5.2m | $10.3m | $30.5m | $87.1m | $104.9m | |
| Provisionand Write Offof Assets | — | — | — | — | — | $1.2m | $6.1m | — | — | — | — | |
| Purchase Of Business | — | — | — | — | — | ($10.2m) | $0 | $0 | — | — | — | |
| Purchase Of Intangibles | — | — | — | — | — | ($530k) | $0 | $0 | — | — | — | |
| Purchase Of Investment | — | — | — | — | — | ($226.0m) | ($213.8m) | $0 | $0 | — | $0 | |
| Purchase Of PPE | — | $941k | $2.6m | $5.2m | $19.9m | $23.7m | ($14.5m) | ($2.4m) | ($1.4m) | ($8.5m) | ($8.5m) | |
| Sale Of Investment | — | — | — | — | — | — | $280.5m | $288.9m | $7.4m | $0 | $0 | |
| Sale Of PPE | — | — | — | — | — | — | $9.5m | $51k | $950k | $0 | $959k | |
| Stock Based Compensation | — | — | — | — | — | — | $64.2m | $66.7m | $95.5m | $116.2m | $121.0m |